Wealth Management Partners LLC grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 25.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,755 shares of the company’s stock after purchasing an additional 6,678 shares during the period. Astera Labs comprises 1.6% of Wealth Management Partners LLC’s holdings, making the stock its 15th largest holding. Wealth Management Partners LLC’s holdings in Astera Labs were worth $5,449,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after buying an additional 1,693,918 shares in the last quarter. State Street Corp lifted its position in shares of Astera Labs by 9.1% during the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after acquiring an additional 195,992 shares during the period. 1832 Asset Management L.P. grew its holdings in shares of Astera Labs by 151.4% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after purchasing an additional 929,600 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Astera Labs by 46.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after purchasing an additional 479,360 shares in the last quarter. Finally, Amundi increased its position in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the period. 60.47% of the stock is owned by institutional investors.
Astera Labs Stock Down 1.7%
Shares of ALAB stock opened at $121.76 on Wednesday. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The company has a market cap of $20.85 billion, a P/E ratio of 99.80, a P/E/G ratio of 2.44 and a beta of 1.74. The business has a fifty day simple moving average of $141.95 and a 200 day simple moving average of $165.11.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the company. Northland Securities boosted their price target on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research note on Tuesday, December 9th. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Royal Bank Of Canada assumed coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price on the stock. Morgan Stanley restated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Citigroup reduced their price target on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $202.22.
Read Our Latest Report on ALAB
Insider Activity at Astera Labs
In related news, CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the sale, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at approximately $23,781,796.23. The trade was a 5.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jack R. Lazar sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $130.00, for a total transaction of $325,000.00. Following the transaction, the director owned 84,851 shares of the company’s stock, valued at approximately $11,030,630. This represents a 2.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 384,292 shares of company stock worth $48,724,919 in the last ninety days. Insiders own 12.50% of the company’s stock.
Astera Labs News Roundup
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Company benefits from robust AI infrastructure demand — management/product roadmaps (Scorpio, Aries, Taurus) and hyperscaler spend are cited as growth drivers for 2026, supporting revenue momentum and longer‑term upside. ALAB Benefits From Strong AI Infrastructure Demand: What’s Ahead?
- Positive Sentiment: Index inclusion and a new shelf filing improve the stock’s public market profile — FTSE All‑World inclusion can create passive fund flows, while a shelf gives management optionality to raise capital if needed. Astera Labs Index Entry And Shelf Filing Shape Capital Access Story
- Neutral Sentiment: Management presented at the Roth conference — the transcript provides additional detail on strategy and product roadmap but contains no new market‑moving surprises. Astera Labs, Inc. (ALAB) Presents at The 38th Annual Roth Conference Transcript
- Neutral Sentiment: Market writeups explaining today’s dip summarize mixed technicals/valuation and short‑term profit‑taking rather than a single fundamental shock. Why Astera Labs, Inc. (ALAB) Dipped More Than Broader Market Today
- Negative Sentiment: Short interest has risen materially (reported ~13.5M shares as of Mar. 13, ~9.1% of shares sold short, ~2.8 days to cover) — higher short positioning increases downside pressure and volatility on negative news or further technical selling.
- Negative Sentiment: Analyst/commentary pieces flag a recent pullback and question near‑term valuation after a strong prior run; that bearish tone can reinforce selling among momentum traders. Is It Too Early To Reconsider Astera Labs (ALAB) After Recent Share Price Pullback
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
